Mohamed Elmeliegy, Ph.D.

Affiliations: 
2012 Molecular Therapeutics and Cell Signaling University of Tennessee Health Science Center, Memphis, TN, United States 
Area:
Pharmacy, Oncology
Google:
"Mohamed Elmeliegy"
Mean distance: 35622
 

Parents

Sign in to add mentor
Clinton Stewart grad student 2012 UTHSC
 (CNS penetration of tyrosine kinase inhibitors in mouse models.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Elmeliegy M, Lang I, Smolyarchuk EA, et al. (2019) Evaluation of the effect of P-glycoprotein inhibition and induction on talazoparib disposition in patients with advanced solid tumors. British Journal of Clinical Pharmacology
Elmeliegy M, Throm SL, Wang F, et al. (2012) Abstract 2742: Cerebral microdialysis for simultaneous sampling of crenolanib (PDGFR inhibitor) and erlotinib (EGFR inhibitor) in mouse models of glioma Cancer Research. 72: 2742-2742
Elmeliegy MA, Carcaboso AM, L Chow LM, et al. (2011) Magnetic resonance imaging-guided microdialysis cannula implantation in a spontaneous high-grade glioma murine model. Journal of Pharmaceutical Sciences. 100: 4210-4
Elmeliegy MA, Carcaboso AM, Tagen M, et al. (2011) Role of ATP-binding cassette and solute carrier transporters in erlotinib CNS penetration and intracellular accumulation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 89-99
Elmeliegy M, Bai F, Juel S, et al. (2011) Abstract 5474: Optimization of a microdialysis method for evaluation of CP-868,596 penetration in glioblastoma murine models using a sensitive liquid chromatography mass spectrometry (LC-MS/MS) method Cancer Research. 71: 5474-5474
Carcaboso AM, Elmeliegy MA, Shen J, et al. (2010) Tyrosine kinase inhibitor gefitinib enhances topotecan penetration of gliomas. Cancer Research. 70: 4499-508
Shen J, Carcaboso AM, Hubbard KE, et al. (2009) Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid. Cancer Research. 69: 5885-92
See more...